| http://www.w3.org/ns/prov#value | - The data from the clinical trials, together with preclinical data and other supporting information that establishes a drug candidate???s safety profile and efficacy, are submitted to the FDA in the form of an NDA or NDA supplement (for approval of a new indication if the product candidate is already approved for another indication).
|
